These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 23990088)

  • 1. [Effectiveness, population-level effects, and heath economics of measles and rubella vaccination].
    Wichmann O; Ultsch B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1260-9. PubMed ID: 23990088
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR; Choe YJ; Go UY; Kim YI; Lee JK
    Vaccine; 2013 May; 31(24):2661-6. PubMed ID: 23602654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the Transmission of Measles and Rubella to Support Global Management Policy Analyses and Eradication Investment Cases.
    Thompson KM; Badizadegan ND
    Risk Anal; 2017 Jun; 37(6):1109-1131. PubMed ID: 28561947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost effectiveness of prevaccination screening of health care workers for immunity to measles, rubella and mumps.
    Ferson MJ; Robertson PW; Whybin LR
    Med J Aust; 1994 Apr; 160(8):478-82. PubMed ID: 8170422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A benefit-cost analysis of two-dose measles immunization in Canada.
    Pelletier L; Chung P; Duclos P; Manga P; Scott J
    Vaccine; 1998; 16(9-10):989-96. PubMed ID: 9682349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health economics of rubella: a systematic review to assess the value of rubella vaccination.
    Babigumira JB; Morgan I; Levin A
    BMC Public Health; 2013 Apr; 13():406. PubMed ID: 23627715
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hot spot: epidemiology of measles and rubella in Germany and the WHO European region].
    Matysiak-Klose D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1231-7. PubMed ID: 23990084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The German National Verification Committee for Measles and Rubella Elimination].
    Matysiak-Klose D; Razum O
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1293-6. PubMed ID: 23990092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessing the cost-effectiveness of different measles vaccination strategies for children in the Democratic Republic of Congo.
    Doshi RH; Eckhoff P; Cheng A; Hoff NA; Mukadi P; Shidi C; Gerber S; Wemakoy EO; Muyembe-Tafum JJ; Kominski GF; Rimoin AW
    Vaccine; 2017 Oct; 35(45):6187-6194. PubMed ID: 28966000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic Review of Health Economic Analyses of Measles and Rubella Immunization Interventions.
    Thompson KM; Odahowski CL
    Risk Anal; 2016 Jul; 36(7):1297-314. PubMed ID: 25545778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Health and economic benefits of mandatory regular vaccination in Slovakia. IV. Measles, rubella and mumps].
    Hudecková H; Straka S; Avdicová M; Rusnáková S
    Epidemiol Mikrobiol Imunol; 2001 Feb; 50(1):31-5. PubMed ID: 11233671
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic evaluation on different two-dose-vaccination-strategies related to Measles, Mumps and Rubella Combined Attenuated Live Vaccine].
    He HQ; Zhang B; Yan R; Li Q; Fu J; Tang XW; Zhou Y; Deng X; Xie SY
    Zhonghua Liu Xing Bing Xue Za Zhi; 2016 Aug; 37(8):1121-6. PubMed ID: 27539345
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Progress in measles and rubella elimination in Iran.
    Esteghamati A; Gouya MM; Zahraei SM; Dadras MN; Rashidi A; Mahoney F
    Pediatr Infect Dis J; 2007 Dec; 26(12):1137-41. PubMed ID: 18043452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An economic analysis of the current universal 2-dose measles-mumps-rubella vaccination program in the United States.
    Zhou F; Reef S; Massoudi M; Papania MJ; Yusuf HR; Bardenheier B; Zimmerman L; McCauley MM
    J Infect Dis; 2004 May; 189 Suppl 1():S131-45. PubMed ID: 15106102
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Progress in the elimination of measles and rubella in the WHO European Region].
    Muscat M; Jankovic D; Goel A; Butler R; Pfeifer D
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2013 Sep; 56(9):1225-30. PubMed ID: 23990083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expansion of Vaccination Services and Strengthening Vaccine-Preventable Diseases Surveillance in Haiti, 2010-2016.
    Tohme RA; Francois J; Cavallaro KF; Paluku G; Yalcouye I; Jackson E; Wright T; Adrien P; Katz MA; Hyde TB; Faye P; Kimanuka F; Dietz V; Vertefeuille J; Lowrance D; Dahl B; Patel R
    Am J Trop Med Hyg; 2017 Oct; 97(4_Suppl):28-36. PubMed ID: 29064356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ; Adhikary G; Ali MW; Ahmed S; Shamsuzzaman M; Odell C; Hashiguchi L; Lim SS; Alam N
    BMC Infect Dis; 2016 Aug; 16():411. PubMed ID: 27519586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Economic analysis of the 1996-1997 mass measles immunization campaigns in South Africa.
    Uzicanin A; Zhou F; Eggers R; Webb E; Strebel P
    Vaccine; 2004 Sep; 22(25-26):3419-26. PubMed ID: 15308367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Activities to catch up and Vaccinate the Susceptible Population in Valencian Community, Spain].
    Martín-Ivorra R; Alguacil-Ramos AM; Lluch-Rodrigo JA; Pastor-Villalba E; Portero-Alonso A
    Rev Esp Salud Publica; 2015; 89(4):419-26. PubMed ID: 26580797
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [National immunization program initiatives-What are their contribution to the elimination of measles and rubella in Germany?].
    Kouros B; Nennstiel U; Liebl B; Ludwig MS
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2019 Apr; 62(4):386-391. PubMed ID: 30788537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.